Ayala Pharmaceuticals Inc (ADXS)

[Mkc12five]

Aduro has and will continue to be a drag on our SP. Just another of many issues we need to overcome. We have "unprecedented" GOG results yet we continue to languish. Nobody knows about us outside academia because of a poor PR department. Hopefully there is a plan for improving the market's knowledge about our platform (operating system) that has multiple shots on goal and how it differs from ADRO specifically and the other immunotherapies in general. Without a real plan to get us out of this dungeon Dan's PR's are going to only be another selling opportunity. A 6 billion buyout is a long way away from a 2 billion market cap and 300 million is what some biotechnology companies lose in their couches. The biotechnology home run is an endangered species. Everyone here know that if we got a major PR tomorrow and opened at 12 there would be plenty of selling as those who have accumulated over the months would look to cash in. News will have to be earth shattering and followed up by equally good news to break the back of the shorts and push the manipulation in the other direction. Until that happens we are going nowhere. And we are all just passengers on train.